Blackhawk Capital Partners’s GSK GSK Stock Holding History

Blackhawk Capital Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-25,283	Closed	-$1.29M	–	98
2020 Q3	$1.29M	Buy	25,283 +1,068	+4%	+$53.5K	1.17%	31
2020 Q2	$1.15M	Sell	24,215 -27	-0.1%	-$1.39K	1.37%	24
2020 Q1	$1.42M	Sell	24,242 -1,362	-5%	-$72.7K	1.27%	30
2019 Q4	$1.37M	Buy	25,604 +110	+0.4%	+$6.12K	1.36%	29
2019 Q3	$1.36M	Buy	25,494 +659	+3%	+$33.9K	1.27%	31
2019 Q2	$1.24M	Buy	+24,835	New	+$1.25M	1.19%	31

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Blackhawk Capital Partners's GSK Position: Q4 2020 in Review

Blackhawk Capital Partners sold out of GSK (GSK) in Q4 2020, closing a stake of 25,283 shares — an estimated $1.29M sold.

Blackhawk Capital Partners first reported a position in GSK in Q2 2019 and held it in 6 quarters. The position peaked at $1.42M in Q1 2020. 819 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

Blackhawk Capital Partners reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
Blackhawk Capital Partners sold 25,283 GSK shares in Q4 2020, an estimated $1.29M.
Blackhawk Capital Partners first reported a position in GSK in Q2 2019 and held it in 6 quarters.
Blackhawk Capital Partners's GSK position peaked at $1.42M in Q1 2020.
819 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Blackhawk Capital Partners's 13F filing for Q4 2020, filed 10 Feb 2021.